Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT07486141
NA

Effect of Vitamin D and Folic Acid on Mild Cognitive Impairment

Sponsor: Capital Medical University

View on ClinicalTrials.gov

Summary

The purpose of this study is to investigate the effects of Vitamin D3 combined with Folic Acid on mild cognitive impairment (MCI). Participants aged 50 to 70 years with MCI will be randomly assigned to three groups: a low-dose Vitamin D3 plus Folic Acid group, a high-dose Vitamin D3 plus Folic Acid group, and a placebo group. The intervention will last for 6 months. The main goal is to observe whether this nutritional intervention can improve or delay the decline of cognitive function.

Official title: Effects and Mechanisms of Vitamin D Combined With Folic Acid and Vitamin B12 on Mild Cognitive Impairment Via Regulation of Key Factors in 27-Hydroxycholesterol Metabolism

Key Details

Gender

All

Age Range

50 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

380

Start Date

2024-11-01

Completion Date

2026-06

Last Updated

2026-03-20

Healthy Volunteers

No

Interventions

DIETARY_SUPPLEMENT

Vitamin D3 (800 IU/d) and Folic Acid(0.4mg/d)

One folic acid tablet and one low-dose Vitamin D3 tablet administered orally once daily at breakfast for 6 months.

DIETARY_SUPPLEMENT

Vitamin D3 (1600 IU/d) and Folic Acid(0.4mg/d)

One folic acid tablet and one high-dose Vitamin D3 tablet administered orally once daily at breakfast for 6 months.

OTHER

Starch Placebo

Two starch placebo tablets administered orally once daily at breakfast for 6 months. The placebo is identical in appearance, color, and smell to the active tablets.

Locations (1)

Capital Medical University

Beijing, Beijing Municipality, China